Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC
NCT07011823
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Triple-Negative Breast Neoplasm
Interventions
RADIATION:
Partial breast-irradiation
Sponsor
Gangnam Severance Hospital